Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 2004, p. 7156-7160, Vol. 70, No. 12
0099-2240/04/$08.00+0 DOI: 10.1128/AEM.70.12.7156-7160.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Noga Bloushtain,1
Michal Shapira,2 and
Udi Qimron1*
Department of Microbiology and Immunology, Faculty of Health Sciences,1 Department of Life Sciences, Faculty of Natural Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel2
Received 15 June 2004/ Accepted 31 July 2004
We have developed a simple method for single-step cloning of any PCR product into a plasmid. A novel selection principle has been applied, in which activation of a drug selection marker is achieved following homologous recombination. In this method a DNA fragment is amplified by PCR with standard oligonucleotides that contain flanking tails derived from the host plasmid and the complete
PR or rrnA1 promoter regions. The resulting PCR product is then electroporated into an Escherichia coli strain harboring both the phage
Red functions and the host plasmid. Upon homologous recombination of the PCR fragment into the plasmid, expression of a drug selection marker is fully induced due to restoration of its truncated promoter, thus allowing appropriate selection. Recombinant plasmid vectors encoding ß-galactosidase and neomycin phosphotransferase were constructed by using this method in two well-known Red systems. This cloning strategy significantly reduces both the time and costs associated with cloning procedures.
Present address: Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»